Effect of weight gain on the development of gestational diabetes
Licencia CC 4.0 (BY-NC-ND) © 2023 Revista Médica del Instituto Mexicano del Seguro Social..
Background: Gestational diabetes mellitus (GDM) refers to diabetes diagnosed in the second or third trimester of pregnancy. Assessing the weight gain in each pregnant women's appointment is a common task of primary care during their visit. However, the implications of this increase in weight for the development of GDM are unknown.
Objective: Evaluate if the greater than expected weight gain (HEWG) in pregnancy is a risk factor for the development of GDM.
Methods: Analytical, observational, longitudinal, retrolective study, which included pregnant women between 15 and 40 years of age with complete follow-up of the preg-nancy with > 2 prenatal check-ups, somatometry and complete medical history was made. During follow-up, the GPME was determined. Odds ratio (OR) and 95% confi-dence intervals (95% CI) were calculated. Variables with significance were entered into a multiple logistic regression model (MLR), where the dependent variable was DMG. The sample size calculation was for convenience.
Results: 1000 pregnant women with a median age of 28 years were included. In the MLR The pre-gestational body mass index (BMI) with overweight had an RM of 1.3 (95% CI 0.86-1.98), BMI with obesity an OR of 2.57 (95% CI 1.6-4.14), the HEWG during pregnancy had an OR 1.14 95% CI (0.71-1.81), Age> 30 years shows an RM of 2.24 (95% CI 1.55-3.25).
Conclusions: HEWG during pregnancy is not an independent risk factor for the devel-opment of GDM. The main ones are age> 30 years and pre-gestational obesity.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
Revista medica del Instituto Mexicano del Seguro Social - 61(2023), Suppl 3 vom: 02. Okt., Seite S460-S467 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Efecto de la ganancia ponderal en el desarrollo de diabetes gestacional |
|---|
| Beteiligte Personen: |
Suárez-Cruz, María Guadalupe [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 09.11.2023 Date Revised 28.12.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.5281/zenodo.8319773 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36426697X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36426697X | ||
| 003 | DE-627 | ||
| 005 | 20231229124156.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.5281/zenodo.8319773 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1241.xml |
| 035 | |a (DE-627)NLM36426697X | ||
| 035 | |a (NLM)37934928 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Suárez-Cruz, María Guadalupe |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of weight gain on the development of gestational diabetes |
| 246 | 3 | 3 | |a Efecto de la ganancia ponderal en el desarrollo de diabetes gestacional |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.11.2023 | ||
| 500 | |a Date Revised 28.12.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Licencia CC 4.0 (BY-NC-ND) © 2023 Revista Médica del Instituto Mexicano del Seguro Social. | ||
| 520 | |a Background: Gestational diabetes mellitus (GDM) refers to diabetes diagnosed in the second or third trimester of pregnancy. Assessing the weight gain in each pregnant women's appointment is a common task of primary care during their visit. However, the implications of this increase in weight for the development of GDM are unknown | ||
| 520 | |a Objective: Evaluate if the greater than expected weight gain (HEWG) in pregnancy is a risk factor for the development of GDM | ||
| 520 | |a Methods: Analytical, observational, longitudinal, retrolective study, which included pregnant women between 15 and 40 years of age with complete follow-up of the preg-nancy with > 2 prenatal check-ups, somatometry and complete medical history was made. During follow-up, the GPME was determined. Odds ratio (OR) and 95% confi-dence intervals (95% CI) were calculated. Variables with significance were entered into a multiple logistic regression model (MLR), where the dependent variable was DMG. The sample size calculation was for convenience | ||
| 520 | |a Results: 1000 pregnant women with a median age of 28 years were included. In the MLR The pre-gestational body mass index (BMI) with overweight had an RM of 1.3 (95% CI 0.86-1.98), BMI with obesity an OR of 2.57 (95% CI 1.6-4.14), the HEWG during pregnancy had an OR 1.14 95% CI (0.71-1.81), Age> 30 years shows an RM of 2.24 (95% CI 1.55-3.25) | ||
| 520 | |a Conclusions: HEWG during pregnancy is not an independent risk factor for the devel-opment of GDM. The main ones are age> 30 years and pre-gestational obesity | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Age | |
| 650 | 4 | |a Body Mass Index | |
| 650 | 4 | |a Complicaciones del Embarazo | |
| 650 | 4 | |a Diabetes Gestacional | |
| 650 | 4 | |a Diabetes, Gestational | |
| 650 | 4 | |a Edad | |
| 650 | 4 | |a Ganancia de Peso Gestacional | |
| 650 | 4 | |a Gestational Weight Gain | |
| 650 | 4 | |a Pregnancy Complications | |
| 650 | 4 | |a Índice de Masa Corporal | |
| 700 | 1 | |a Rivas-Ruíz, Rodolfo |e verfasserin |4 aut | |
| 700 | 1 | |a Sarmiento-Galván, Dulce Kristel |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Valle, Paloma Gabriela |e verfasserin |4 aut | |
| 700 | 1 | |a Mondragón-Sandoval, Eva Xóchitl |e verfasserin |4 aut | |
| 700 | 1 | |a López-Farias, Marco Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Rivera-Mendoza, Juan Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Abasolo-Ramírez, Eduardo |e verfasserin |4 aut | |
| 700 | 1 | |a Carmona-Sierra, Fairt Vladimir |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista medica del Instituto Mexicano del Seguro Social |d 2005 |g 61(2023), Suppl 3 vom: 02. Okt., Seite S460-S467 |w (DE-627)NLM156363798 |x 0443-5117 |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2023 |g number:Suppl 3 |g day:02 |g month:10 |g pages:S460-S467 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5281/zenodo.8319773 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2023 |e Suppl 3 |b 02 |c 10 |h S460-S467 | ||